Effect Of The System In The Enriched Fat Metabolism Of The Child Reached Mitochondrial Cytopathy

Not Applicable

Completed

• Conditions: Mitochondrial Cytopathies Disorders
• Interventions: Other: high fat diet; Other: normal fat diet

• Registration Number: NCT02385565
• Lead Sponsor: University Hospital, Lille

Brief Summary

The aim of the present study is to compare Resting Energy Expenditure (REE) between normal fat diet (NFD) as a control vs high fat diet (HFD) as a treatment in Mitochondrial cytopathies disorders ( MID's ) patients. Secondary objectives is to compare diet induced thermogenesis (DIT) and body composition between NFD vs HFD.

This study is a randomized cross-over study. Normal fat diet (ie 10 % proteins, 45 % lipids, 45 % carbohydrates) is the imposed diet at baseline, high fat diet (ie 10 % proteins, 30 % lipids, 60 % carbohydrates is used according to the cross-over design trial. Main evaluation criteria is REE and second evaluation criteria is DIT both measured by indirect calorimetry ). 36 included MID subjects will be included in this study. Main evaluation criteria and second evaluation criteria will be measured at baseline, 1 month, 2 month and 3 month.

Detailed Description

REE and DIT are measured by indirect calorimetry . The device used is a using an open-circuit ventilated hood system (QUARK RMR®, Cosmed, Pavona; Italy). The respiration quo- tient (RQ) and flow settings are calibrated by reference to alcohol combustion every six months. Before each test, the calorimeter is calibrated with a reference gas mixture (5% CO2, 95% O2 v/v). Expired carbon di- oxide (VCO2) and inspired oxygen (VO2) -flows are recorded, as well as the RQ. EE is calculated every minute from oxygen consumption (VO2 in ml/min) and carbon dioxide production (VCO2 in ml/min) using the Weir formula without protein correction. DIT is measured during 6 hours after a calibrated breakfast (normal fat diet or high fat diet according to the cross-over design) as 30% of theoric energy intake.

Study Timeline

• Study Start: 2004-02
• Primary Completion: 2008-12
• Study Completion: 2009-12
• Status Verified: 2015-03
• Study First Submitted: 2015-03-02
• Study First Submitted QC: 2015-03-10
• Last Update Submitted: 2015-03-10
• Study First Posted: 2015-03-11
• Last Update Posted: 2015-03-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

• 5 to 21 years-old children,

  • Children with a proven mitochondrial cytopathy documented on biopsies by histology, histoenzymology, ultrastructure and enzyme assay and/or on body fluids by laboratory markers including lactacidemia, metabolic acidosis, increased CSF lactate, lactate/pyruvate and beta-hydroxybutyrate/acetoacetate ratios, paradoxical postprandial ketonemia, alaninemia, citrullinemia, plasma acylcarnitines.
  • Children on the usual diet (30% lipids, 60% glucides and 10% proteins) for at least 1 month.
  • Informed consent of the 2 parents and from the child when in age to express a consent.
  • Child with a social security cover.

Exclusion Criteria

• Acute infection (fever > 38.5°C for more than 6h) within 7 days prior to the study.
• Disability for understanding and following the protocol
• Rejection of the study by the patient or failure to comply to the protocol

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
high fat diet	high fat diet	10 % proteins, 30 % lipids, 60 % carbohydrates
Normal fat diet	normal fat diet	10 % proteins, 45 % lipids, 45 % carbohydrates

Primary Outcome Measures

Name	Time	Method
resting energy expenditure	up to 3 months	resting energy expenditure measured by indirect calorimetry

Secondary Outcome Measures

Name	Time	Method
body composition	baseline, 1 month, 2 months, 3 months	body composition by DEXA
diet induced thermogenesis	baseline, 1 month, 2 months, 3 months	diet induced thermogenesis measured by indirect calorimetry

Trial Locations

Locations (1)

Centre d'Investigation Clinique; 🇫🇷 Paris, France